IL-10 R alpha 분자 정보
Molecule Name
Interleukin 10 receptor
분자 별명
Interleukin-10 receptor subunit alpha,IL-10 receptor subunit alpha,IL-10R subunit alpha,IL-10RA,CDw210a,Interleukin-10 receptor subunit 1,IL-10R subunit 1,IL-10R1,CD210,IL10RA,IL10R
Drug Development Progress
임상 약물 수9
시판 약물 수0
최고 연구 개발 단계Phase 3 Clinical
표적 별명
Receptors， Interleukin-10
IL-10 R alpha 제품 목록
You Have Viewed 0 Of 0 Results
임상 약물 정보
| 영어 이름 | 연구 코드 | 연구 개발 단계 | 회사 | 적응증 | 임상 시험 |
|---|---|---|---|---|---|
| IAE-0972 | IAE-0972 | Phase 3 Clinical | SunHo (China) BioPharmaceutical Co Ltd | Carcinoma, Basosquamous; Carcinoma, Hepatocellular; Colorectal Neoplasms; Nasopharyngeal Carcinoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck | 상세 |
| Recombinant anti-human EGFR antibody/IL-10 bispecific Fc fusion protein(Dingfu Biotarget) | CmAb-(IL10)2; DF203; DF-203 | Phase 2 Clinical | Dingfu Biotarget Co Ltd | Ascites; Pleural Effusion, Malignant; Solid tumours | 상세 |
| AG-019 | AG-019 | Phase 2 Clinical | Precigen Actobio Inc | Diabetes Mellitus, Type 1 | 상세 |
| Meta 10C-IL-10 TILs | Meta10-TIL; Meta 10C-IL-10 TILs | Phase 2 Clinical | Leman Biotech Co Ltd | Neoplasms; Solid tumours | 상세 |
| IBB-0979 | IBB0979; IBB-0979 | Phase 2 Clinical | SunHo (China) BioPharmaceutical Co Ltd | Carcinoma, Ovarian Epithelial; Fallopian Tube Neoplasms; Neoplasms; Peritoneal Neoplasms; Small Cell Lung Carcinoma; Solid tumours | 상세 |
| Vimekofusp | AMT-101 (Applied Molecular Transport) | Phase 2 Clinical | Applied Molecular Transport | Colitis, Ulcerative | 상세 |
| F8-IL10 | F8-IL10; PF-06687234 | Phase 2 Clinical | Philogen Spa | Arthritis, Rheumatoid; Colitis, Ulcerative; Inflammatory Bowel Diseases | 상세 |
| PEG-ilodecakin | AM-0010 | Phase 1 Clinical | Armo Biosciences, Merck Sharp & Dohme Corp | Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colorectal Neoplasms; Granulomatosis with Polyangiitis; Melanoma; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Solid tumours; Vasculitis | 상세 |
| Diakine-DK2 10 (EGFR) | DK210; DK-2-10 | Phase 1 Clinical | Deka Biosciences Inc | Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colorectal Neoplasms; Genital Neoplasms, Female; Head and Neck Neoplasms; Kidney Neoplasms; Neoplasms; Pancreatic Neoplasms; Skin Neoplasms; Solid tumours | 상세 |